
    
      -  Two weeks Duloxetine 60 mg Open-Label Period

        -  Randomization to Double-Blind Treatment Period: 10 weeks Milnacipran (direct switch) or
           10 weeks placebo (one week blinded 30 mg duloxetine)

        -  One week Double-Blind Down-Taper Period
    
  